Please enable Javascript
Benjamin L. Schlechter, MD
Benjamin L. Schlechter, MD, of Dana-Farber Cancer Institute
Articles by Benjamin L. Schlechter, MD
Bot/Bal in MSS CRC: Efficacy in Non-Liver Metastatic Sites
Benjamin L. Schlechter, MD
Colorectal Cancer
|
March 13, 2025
Dr. Schlechter also highlights how this research may effect long-term efficacy and durability of response in patients.
View More
Investigative Safety, Clinical Activity of CAR-T in Metastatic Colorectal Cancer
Benjamin L. Schlechter, MD
Colorectal Cancer
|
March 13, 2025
Dr. Schlechter discusses a phase 1 dose escalation study of a novel coupled CAR-T therapy for patients with mCRC.
View More